341 related articles for article (PubMed ID: 15762035)
1. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.
Serter R; Demirbas B; Korukluoglu B; Culha C; Cakal E; Aral Y
J Endocrinol Invest; 2004 Nov; 27(10):897-903. PubMed ID: 15762035
[TBL] [Abstract][Full Text] [Related]
2. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
[TBL] [Abstract][Full Text] [Related]
4. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
5. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
6. [Effect of treatment with levothyroxine in the lipid profile of the patients with subclinical hypothyroidism].
Prats Julià M
Endocrinol Nutr; 2009 Jan; 56(1):13-7. PubMed ID: 19627704
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.
Razvi S; Ingoe L; Keeka G; Oates C; McMillan C; Weaver JU
J Clin Endocrinol Metab; 2007 May; 92(5):1715-23. PubMed ID: 17299073
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis.
Tagami T; Tamanaha T; Shimazu S; Honda K; Nanba K; Nomura H; Yoriko SU; Usui T; Shimatsu A; Naruse M
Endocr J; 2010; 57(3):253-8. PubMed ID: 20032565
[TBL] [Abstract][Full Text] [Related]
9. A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism.
Zhao M; Liu L; Wang F; Yuan Z; Zhang X; Xu C; Song Y; Guan Q; Gao L; Shan Z; Zhang H; Zhao J
Thyroid; 2016 Aug; 26(8):1019-29. PubMed ID: 27270263
[TBL] [Abstract][Full Text] [Related]
10. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
11. A Study of Lipid Profile in Patients with Subclinical Hypothyroidism.
S S; Mb V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443331
[TBL] [Abstract][Full Text] [Related]
12. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.
Turhan S; Sezer S; Erden G; Guctekin A; Ucar F; Ginis Z; Ozturk O; Bingol S
Ann Saudi Med; 2008; 28(2):96-101. PubMed ID: 18398274
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Luboshitzky R; Aviv A; Herer P; Lavie L
Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
[TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.
Ganotakis ES; Mandalaki K; Tampakaki M; Malliaraki N; Mandalakis E; Vrentzos G; Melissas J; Castanas E
Angiology; 2003; 54(5):569-76. PubMed ID: 14565632
[TBL] [Abstract][Full Text] [Related]
17. Serum lipids, tHcy, hs-CRP, MDA and PON-1 levels in SCH and overt hypothyroidism: effect of treatment.
Singh S; Dey Sarkar P
Acta Biomed; 2014 Aug; 85(2):127-34. PubMed ID: 25245648
[TBL] [Abstract][Full Text] [Related]
18. Even mildly elevated TSH is associated with an atherogenic lipid profile in postmenopausal women with subclinical hypothyroidism.
Geng H; Zhang X; Wang C; Zhao M; Yu C; Zhang B; Wang Y; Ban B; Zhao J
Endocr Res; 2015; 40(1):1-7. PubMed ID: 24679183
[TBL] [Abstract][Full Text] [Related]
19. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
20. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.
Miura S; Iitaka M; Yoshimura H; Kitahama S; Fukasawa N; Kawakami Y; Sakurai S; Urabe M; Sakatsume Y; Ito K
Intern Med; 1994 Jul; 33(7):413-7. PubMed ID: 7949641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]